Evaluation Safety of 3-FL (3-Fucosyllactose) as a novel food published by EFSA
Aug 04, 2021
The NF is mainly composed of the human-identical milk oligosaccharide (HiMO) 3-FL but also contains D-lactose and its monomers, L-fucose and a small fraction of other related saccharides. The NF is produced by fermentation with a genetically modified strain of Escherichia coli K-12. The information provided on the manufacturing process, composition and specifications of the NF does not raise safety concerns. The applicant intends to add the NF in a variety of foods, including infant and follow-on formula, foods for infants and toddlers, foods for special medical purposes and food supplements. The Panel concludes that the NF is safe under the proposed conditions of use.
For further information (in English), click on the Link
Tags:
EFSA to develop structured database on novel food information
European Union
Sep 08, 2023
Proposal on the use of insects as novel foods
Romania
Sep 07, 2023
New food substances under review
China
Aug 14, 2023
Amended conditions of use of novel food astaxanthin-rich oleoresin
European Union
Aug 03, 2023
Amended conditions of use of novel food 3′-Sialyllactose sodium salt
European Union
Aug 03, 2023
Amended specifications of novel food lacto-N-neotetraose (microbial source)
European Union
Aug 03, 2023
Safety assessment requirements for Novel Foods revised
Singapore
Jul 19, 2023
Yerba Mate under evaluation as new food raw material
China
Jun 28, 2023
New online system for application of regulated products
UK
Jun 26, 2023
Executive summary on novel foods regulatory framework review published by FSA
UK
Jun 08, 2023
Change in conditions of use of protein extract from pig kidneys as a novel food
European Union
May 19, 2023
Commission authorizes iron milk caseinate as a novel food
European Union
May 19, 2023
Commission authorizes cellobiose as a novel food
European Union
May 18, 2023
Commission extends uses of the novel foods 2’-Fucosyllactose and lacto-N-neotetraose (LNnT)
European Union
May 18, 2023
Commission authorizes human‐identical milk oligosaccharide as a novel food
European Union
May 18, 2023
Expertise in countries
- Argentina
- Australia
- Brazil
- Brunei
- Cambodia
- Canada
- Chile
- Colombia
- Ecuador
- Egypt
- European Union
- India
- Indonesia
- Laos
- Japan
- Malaysia
- Mexico
- Myanmar
- New Zealand
- Nigeria
- Paraguay
- Philippines
- Peru
- Russia
- Saudi Arabia
- Singapore
- South Africa
- South Korea
- Switzerland
- Thailand
- Turkey
- UAE
- UK
- Ukraine
- Uruguay
- USA
- Vietnam
